Downregulation of KDR following treatment with Kushen suggests that inhibition of the VEGF-A/KDR signaling pathway may help mitigate vascular and immune dysfunction, thereby alleviating inflammation and facilitating mucosal healing in IBD. Here, KDR is linked to inflammatory bowel disease.